These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 19401303)
1. A competition-based assay for the screening of species-specific antibiotics. Granieri L; Miller OJ; Griffiths AD; Merten CA J Antimicrob Chemother; 2009 Jul; 64(1):62-8. PubMed ID: 19401303 [TBL] [Abstract][Full Text] [Related]
2. A competitive co-cultivation assay for cancer drug specificity evaluation. El Debs BW; Tschulena U; Griffiths AD; Merten CA J Biomol Screen; 2011 Sep; 16(8):818-24. PubMed ID: 21788393 [TBL] [Abstract][Full Text] [Related]
3. Comparison of assays for detection of agents causing membrane damage in Staphylococcus aureus. O'Neill AJ; Miller K; Oliva B; Chopra I J Antimicrob Chemother; 2004 Dec; 54(6):1127-9. PubMed ID: 15531595 [TBL] [Abstract][Full Text] [Related]
4. Validation for high-throughput screening of a VanRS-based reporter gene assay for bacterial cell wall inhibitors. De Pascale G; Grigoriadou C; Losi D; Ciciliato I; Sosio M; Donadio S J Appl Microbiol; 2007 Jul; 103(1):133-40. PubMed ID: 17584459 [TBL] [Abstract][Full Text] [Related]
5. XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity. Ooi N; Miller K; Hobbs J; Rhys-Williams W; Love W; Chopra I J Antimicrob Chemother; 2009 Oct; 64(4):735-40. PubMed ID: 19689976 [TBL] [Abstract][Full Text] [Related]
6. A modular, fully integrated ultra-high-throughput screening system based on confocal fluorescence analysis techniques. Jäger S; Garbow N; Kirsch A; Preckel H; Gandenberger FU; Herrenknecht K; Rüdiger M; Hutchinson JP; Bingham RP; Ramon F; Bardera A; Martin J J Biomol Screen; 2003 Dec; 8(6):648-59. PubMed ID: 14711390 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 2-mercapto-1,3-benzothiazole derivatives with potential antimicrobial activity. Franchini C; Muraglia M; Corbo F; Florio MA; Di Mola A; Rosato A; Matucci R; Nesi M; van Bambeke F; Vitali C Arch Pharm (Weinheim); 2009 Oct; 342(10):605-13. PubMed ID: 19753564 [TBL] [Abstract][Full Text] [Related]
8. A robust screen for novel antibiotics: specific knockout of the initiator of bacterial DNA replication. Fossum S; De Pascale G; Weigel C; Messer W; Donadio S; Skarstad K FEMS Microbiol Lett; 2008 Apr; 281(2):210-4. PubMed ID: 18312360 [TBL] [Abstract][Full Text] [Related]
9. Staphylococcus saprophyticus ATCC 15305 is internalized into human urinary bladder carcinoma cell line 5637. Szabados F; Kleine B; Anders A; Kaase M; Sakinç T; Schmitz I; Gatermann S FEMS Microbiol Lett; 2008 Aug; 285(2):163-9. PubMed ID: 18573154 [TBL] [Abstract][Full Text] [Related]
10. An integrated approach to improved toxicity prediction for the safety assessment during preclinical drug development using Hep G2 cells. Noor F; Niklas J; Müller-Vieira U; Heinzle E Toxicol Appl Pharmacol; 2009 Jun; 237(2):221-31. PubMed ID: 19332084 [TBL] [Abstract][Full Text] [Related]
14. [Determination of antibiotics using luminescent Escherichia coli and serum]. Vlasova II; Asrieli TV; Gavrilova EM; Danilov VS Prikl Biokhim Mikrobiol; 2007; 43(4):471-8. PubMed ID: 17929576 [TBL] [Abstract][Full Text] [Related]
15. High-throughput screening of model bacteria. Zlitni S; Blanchard JE; Brown ED Methods Mol Biol; 2009; 486():13-27. PubMed ID: 19347613 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of a microbiological agar assay for determination of cefuroxime sodium in pharmaceutical preparations. Schmidt CA; Agarrayua DA; Laporta LV; Machado JC; Manfio ML; Bittencourt CF J Microbiol Methods; 2009 Jun; 77(3):308-15. PubMed ID: 19344741 [TBL] [Abstract][Full Text] [Related]
17. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus. Pillai SK; Wennersten C; Venkataraman L; Eliopoulos GM; Moellering RC; Karchmer AW Clin Infect Dis; 2009 Oct; 49(8):1169-74. PubMed ID: 19769538 [TBL] [Abstract][Full Text] [Related]
18. A Staphylococcus aureus fitness test platform for mechanism-based profiling of antibacterial compounds. Donald RG; Skwish S; Forsyth RA; Anderson JW; Zhong T; Burns C; Lee S; Meng X; LoCastro L; Jarantow LW; Martin J; Lee SH; Taylor I; Robbins D; Malone C; Wang L; Zamudio CS; Youngman PJ; Phillips JW Chem Biol; 2009 Aug; 16(8):826-36. PubMed ID: 19716473 [TBL] [Abstract][Full Text] [Related]
19. Measurement of effects of antibiotics in bioluminescent Staphylococcus aureus RN4220. Tenhami M; Hakkila K; Karp M Antimicrob Agents Chemother; 2001 Dec; 45(12):3456-61. PubMed ID: 11709324 [TBL] [Abstract][Full Text] [Related]
20. A lux-based Staphylococcus aureus bioluminescence screening assay for the detection/identification of antibiotics and prediction of antibiotic mechanisms. Yang Z; Cui Q; Zhang M; Li Z; Wang M; Xu H J Antibiot (Tokyo); 2020 Dec; 73(12):828-836. PubMed ID: 32678336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]